Leucomycins
DBCAT001762Pharmacologic class
An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. A DrugBank category of 3 drugs. 1 of them is approved.
What you can answer from here — as of August 24, 2016
Which targets do Leucomycins share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account